Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant

The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibits reduced susceptibility to vaccine-induced neutralizing antibodies, requiring a boost to generate protective immunity. We assess the magnitude and short-term durability of neutralizing antibodies after homolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyke, Kirsten E., Atmar, Robert L., Islas, Clara Dominguez, Posavad, Christine M., Szydlo, Daniel, Paul Chourdhury, Rahul, Deming, Meagan E., Eaton, Amanda, Jackson, Lisa A., Branche, Angela R., El Sahly, Hana M., Rostad, Christina A., Martin, Judith M., Johnston, Christine, Rupp, Richard E., Mulligan, Mark J., Brady, Rebecca C., Frenck, Robert W., Bäcker, Martín, Kottkamp, Angelica C., Babu, Tara M., Rajakumar, Kumaravel, Edupuganti, Srilatha, Dobrzynski, David, Coler, Rhea N., Archer, Janet I., Crandon, Sonja, Zemanek, Jillian A., Brown, Elizabeth R., Neuzil, Kathleen M., Stephens, David S., Post, Diane J., Nayak, Seema U., Suthar, Mehul S., Roberts, Paul C., Beigel, John H., Montefiori, David C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212999/
https://www.ncbi.nlm.nih.gov/pubmed/35798000
http://dx.doi.org/10.1016/j.xcrm.2022.100679

Ejemplares similares

Ejemplares similares